Ignite Creation Date:
2025-12-24 @ 2:47 PM
Ignite Modification Date:
2025-12-28 @ 5:13 PM
Study NCT ID:
NCT01131559
Status:
TERMINATED
Last Update Posted:
2014-03-05
First Post:
2010-03-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Adjunctive Lisdexamfetamine (LDX) in Bipolar Depression
Sponsor:
Lindner Center of HOPE
Organization:
Study Overview
Official Title:
Adjunctive Lisdexamfetamine in Bipolar Depression
Status:
TERMINATED
Status Verified Date:
2014-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Sponsor halted study.
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The specific aim of this study is to evaluate the efficacy and tolerability of lisdexamfetamine in the adjunctive treatment of bipolar disorder.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: